Calcium‐Doped Organosilicate Nanoparticles as Gene Delivery Vehicles for Bone Cells
Source abstract
Abstract
Calcium-doped organosilicate nanoparticles for gene delivery are prepared by using a surfactant-mediated sol-gel synthesis. The enhanced uptake of these nanoparticles by osteoblast cells (see figure) makes them promising candidates for the transfection of bone cells. The complexes of Ca-SiO2 nanoparticles with DNA transfect bone cells effectively without inducing cytotoxicity in vitro.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (61)
Show source-provided references
1. 10.1016/S0168-3659(02)00320-610.1016/S0168-3659(02)00320-6 ↗
2. 10.1016/j.jconrel.2003.12.02010.1016/j.jconrel.2003.12.020 ↗
3. 10.1080/10717540131690689210.1080/107175401316906892 ↗
4. 10.1016/j.ijpharm.2003.10.03810.1016/j.ijpharm.2003.10.038 ↗
5. 10.1021/bc034125f10.1021/bc034125f ↗
6. 10.1016/S0378-5173(02)00452-010.1016/S0378-5173(02)00452-0 ↗
7. 10.1021/bm049577p10.1021/bm049577p ↗
8. 10.1016/j.addr.2004.02.01410.1016/j.addr.2004.02.014 ↗
9. 10.2174/138161205338213310.2174/1381612053382133 ↗
10. 10.1529/biophysj.103.03348010.1529/biophysj.103.033480 ↗
11. 10.1016/j.bbamem.2004.04.00310.1016/j.bbamem.2004.04.003 ↗
12. 10.1093/nar/gki14210.1093/nar/gki142 ↗
13. 10.1021/bi048519l10.1021/bi048519l ↗
14. 10.1093/nar/24.11.217610.1093/nar/24.11.2176 ↗
15. 10.1002/bit.2021510.1002/bit.20215 ↗
16. 10.1073/pnas.19258149910.1073/pnas.192581499 ↗
17. L. Huang E. Viroontchatapan inNonviral Vectors for Gene Therapy (Eds: L. Huang M. C. Hung E. Wagner) Academic Press San Diego CA1999 p. 4.
18. Sochanik A. · Acta Biochim. Pol. · 1996 · 43 · 29310.18388/abp.1996_4497 ↗
19. 10.1023/A:102098970901910.1023/A:1020989709019 ↗
20. 10.1089/hum.1997.8.6-68910.1089/hum.1997.8.6-689 ↗
21. 10.1016/j.ymthe.2004.03.02010.1016/j.ymthe.2004.03.020 ↗
22. 10.1073/pnas.040721810110.1073/pnas.0407218101 ↗
23. Rabovsky J. · Scand. J. Work Environ. Health · 1999 · 21 · 108
24. 10.1006/rtph.1994.103510.1006/rtph.1994.1035 ↗
25. 10.1093/toxsci/56.2.40510.1093/toxsci/56.2.405 ↗
26. 10.1021/cm051014c10.1021/cm051014c ↗
27. 10.1021/bc000063710.1021/bc0000637 ↗
28. 10.2174/156652303457833910.2174/1566523034578339 ↗
29. 10.1016/S0928-4931(02)00238-210.1016/S0928-4931(02)00238-2 ↗
30. 10.1016/S0378-5173(03)00380-610.1016/S0378-5173(03)00380-6 ↗
31. 10.1016/j.jconrel.2003.11.01910.1016/j.jconrel.2003.11.019 ↗
32. 10.1021/ja046275m10.1021/ja046275m ↗
33. 10.1073/pnas.040803910110.1073/pnas.0408039101 ↗
34. 10.1021/bp049648w10.1021/bp049648w ↗
35. 10.1002/anie.20050181910.1002/anie.200501819 ↗
36. 10.1111/j.1151-2916.1998.tb02540.x10.1111/j.1151-2916.1998.tb02540.x ↗
37. 10.1002/jor.110018012010.1002/jor.1100180120 ↗
38. 10.1016/S0169-409X(98)00020-910.1016/S0169-409X(98)00020-9 ↗
39. 10.1002/(SICI)1521-2254(199903/04)1:2<121::AID-JGM26>3.0.CO;2-J10.1002/(SICI)1521-2254(199903/04)1:2<121::AID-JGM26>3.0.CO;2-J ↗
40. 10.1016/S0142-9612(99)00179-910.1016/S0142-9612(99)00179-9 ↗
41. 10.1177/0363546503031003270110.1177/03635465030310032701 ↗
42. 10.1517/13543784.9.7.157310.1517/13543784.9.7.1573 ↗
43. 10.1016/S0030-5898(05)70118-810.1016/S0030-5898(05)70118-8 ↗
44. 10.1016/S0006-291X(03)00858-110.1016/S0006-291X(03)00858-1 ↗
45. 10.2106/00004623-200206000-0002210.2106/00004623-200206000-00022 ↗
46. 10.1089/1043034995001722010.1089/10430349950017220 ↗
47. 10.1097/00003086-199810001-0001610.1097/00003086-199810001-00016 ↗
48. 10.1586/14737159.5.6.89310.1586/14737159.5.6.893 ↗
49. 10.1002/jbm.a.3026710.1002/jbm.a.30267 ↗
50. 10.1016/j.gene.2004.07.01510.1016/j.gene.2004.07.015 ↗
51. 10.1163/156856205284330210.1163/1568562052843302 ↗
52. 10.1163/156856205284333910.1163/1568562052843339 ↗
53. 10.1038/nmat97410.1038/nmat974 ↗
54. 10.1016/0021-9797(68)90272-510.1016/0021-9797(68)90272-5 ↗
55. 10.1038/nbt84310.1038/nbt843 ↗
56. 10.1016/S0928-0987(01)00218-410.1016/S0928-0987(01)00218-4 ↗
57. S. Moudgil Ph.D. Thesis Massachusetts Institute of Technology Cambridge MA2004.
58. 10.1038/2709410.1038/27094 ↗
59. Samples for cellular uptake were prepared by seeding cells in 75‐cm2tissue culture flasks and adding the particles after day 1 of cell attachment. The cell‐particle samples were incubated for at least 24 h to allow for maximum uptake. The cells were then washed once in phosphate buffered saline (PBS Invitrogen) passaged and resuspended in a 2% paraformaldehyde (Sigma) solution. They were allowed to incubate at room temperature for 2 h in order to fix them in solution. The fixed cells were then stained with SYBR Green I (Molecular Probes) a fluorescent probe that would emit in the FITC region upon binding to silica nanoparticles. Fluorescent particle uptake was quantified through FACS of the stained cell suspensions. Uptake values were calculated as shifts in the mean fluorescence of cell populations relative to the control cell population with no particles. Calibration curves for particle fluorescence were generated by measuring fluorescence vs. particle wt% in an Fmax microplate spectrofluorometer (Molecular Devices) using a 485‐nm excitation/538‐nm emission filter. The particle fluorescence data were analyzed using Softmax PRO (Molecular Devices) and all results were normalized to the fluorescence signal of fluorescent 10‐nm Ca‐SiO2particles.
60. 10.1016/S1357-2725(01)00142-X10.1016/S1357-2725(01)00142-X ↗
61. 10.1038/7188910.1038/71889 ↗